SCHEDULE 1 Modifications to the 2013 Regulations for pre-IP completion day cases
Regulation 16
1 The modifications of the 2013 Regulations referred to in regulation 16 are that those Regulations are to be read as if—
(a) in regulation 2 (interpretation)—
(i) in the definition of “resident patient”, for “the United Kingdom is” there were substituted “ immediately before IP completion day the United Kingdom was ”;
Words in Sch. 1 substituted (31.12.2020 immediately before IP completion day) by The Reciprocal and Cross-Border Healthcare (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1348), regs. 1, 15(a)
(ii) in the definition of “visiting patient”, for “a member State other than the United Kingdom is” there were substituted “ immediately before IP completion day a member State other than the United Kingdom was ”;
(b) in the heading to regulation 5 (national contact point: information about treatment in another member State), for “another member State” there were substituted “ a member State ”;
(c) in regulation 5—
(i) for references to “other member States” there were substituted “ member States ”;
(ii) for the reference to “another member State” there were substituted “ a member State ”;
(d) regulation 5A (National Contact Point: information about prescriptions intended to be used in another member State) were omitted;
(e) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sch. 1 para. 1(e) omitted (31.12.2020 immediately before IP completion day) by virtue of The Reciprocal and Cross-Border Healthcare (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1348), regs. 1, 15(b)
(f) regulation 7 (National Contact Point: duty to consult) were omitted;
(g) in regulation 12—
(i) in paragraph (2) for “P is” there were substituted “ immediately before IP completion day P was ”;
(ii) in paragraph (2)(a), for “is resident” there were substituted “ was resident ”;
(iii) in paragraph (2)(b), for “is the competent member State” there were substituted “ was the competent member State ”;
(iv) in paragraph (4)(b) at the end there were inserted “as it had effect immediately before IP completion day”;
(h) the schedule (elements that must be included in prescriptions intended to be used in another member State) were omitted.
Sch. 1 para. 1 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(1)
Words in Sch. 1 heading substituted (31.12.2020 immediately before IP completion day) by The Reciprocal and Cross-Border Healthcare (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1348), regs. 1, 15(a)

SCHEDULE 2 Modifications to the 2013 Regulations for cross-border arrangements
Regulation 17
1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sch. 2 omitted (31.12.2020 immediately before IP completion day) by virtue of The Reciprocal and Cross-Border Healthcare (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1348), regs. 1, 16